Recent Articles

Be Careful Before Loving Leveraged Biotech ETFs

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs. More 

All About Nothing: Stock ETFs Celebrate Zero Percent Rate Policy

Sector ETFs rocketed off recent intra-day lows as investors believed the Fed will not move soon to raise interest rates. Now what? More 

Why the S&P 500 Is Likely To Revisit This Correction Low

The Fed's decision to leave interest rates should've vaulted the market higher. It's time to get concerned over the next drop in the S&P 500 More 

3 Investments to Make While Living In the Economic Twilight Zone

Recent strong economic news belies the belief that in reality the economy is not doing very well. Here are 3 investments we've made to get through More 

Sector SPDRs: 3 Long-Term Plays to Make

Always keep your eyes not just on individual stocks, but big, broad sector funds like the Sector SPDRs. Here are three that make for great long-term investments. More 

Affordable Care Act Turns 5: Healthcare Stocks Still Soaring

The fifth anniversary of the Affordable Care Act marks a half-decade of remarkable outperformance on the part of healthcare stocks. More 

Beat the Market With These 9 Sector ETFs

Indexing doesn't have to mean just dumping your nest egg into an S&P 500 fund. The Select Sector SPDRs can help you add value by letting you go all in (or all out) of individual sectors. More